Bruce C. Cozadd
2010
In 2010, Bruce C. Cozadd earned a total compensation of $1.9M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 130% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,300 |
|---|---|
| Option Awards | $1,163,414 |
| Salary | $496,877 |
| Other | $1,437 |
| Total | $1,929,028 |
Cozadd received $1.2M in option awards, accounting for 60% of the total pay in 2010.
Cozadd also received $267.3K in non-equity incentive plan, $496.9K in salary and $1.4K in other compensation.
Rankings
In 2010, Bruce C. Cozadd's compensation ranked 3,174th out of 10,439 executives tracked by ExecPay. In other words, Cozadd earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,174 out of 10,439 | 70th |
Division Manufacturing | 1,106 out of 3,838 | 71st |
Major group Chemicals And Allied Products | 212 out of 921 | 77th |
Industry group Drugs | 113 out of 680 | 83rd |
Industry Pharmaceutical Preparations | 88 out of 481 | 82nd |
Source: SEC filing on June 12, 2013.
Cozadd's colleagues
We found three more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2010.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019